RFA- Advancing Genetic Risk Assessment for Type 1 Diabetes: Improving Prediction and Clinical Translation Grant

The RFA aims to advance genetic risk assessment for type 1 diabetes (T1D), enhancing prediction across diverse ancestral backgrounds and refining genetic risk scores (GRS). This initiative will support real-world screening and the prevention of T1D. Grants of up to $900,000 are available for non-profit and for-profit organizations, including academic institutions and industry partners, over a period of three years. Breakthrough T1D is dedicated to making T1D a condition of the past.

Breakthrough T1D
Founded in 1970 by families whose loved ones had been diagnosed with type 1 diabetes (T1D), Breakthrough T1D is a tax-exempt nonprofit 501(c)3 organization.
We lead the way to more effective solutions by connecting the brightest minds to advance treatments, influence policy, and improve access to care.​ By driving innovation forward, Breakthrough T1D will make type 1 diabetes a condition of the past.
Advancing Genetic Risk Assessment for Type 1 Diabetes: Improving Prediction and Clinical Translation
Summary
The main goal of this funding opportunity is to enhance genetic risk assessment for type 1 diabetes (T1D), with a focus on improving prediction across ancestral backgrounds and advancing genetic risk scores (GRS) to support future use in real-world screening, and the detection and prevention of T1D.This Request for Applications (RFA) will award grants to non-profit and for-profit entities such as academic institutions and industry partners of up to $900,000.00 each and up to 3 years.